HOME >> MEDICINE >> NEWS
UCLA, Italian chemists move closer to solving Lou Gehrig's disease mystery

Chemists from UCLA and the University of Florence in Italy may have solved an important mystery about a protein that plays a key role in a particular form of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrigs disease, a progressive, fatal neurodegenerative disorder that strikes without warning.

Joan Selverstone Valentine, UCLA professor of chemistry and biochemistry, has studied the protein copper-zinc superoxide dismutase since the 1970s, long before it was implicated in ALS in 1993. Since the link was discovered, Valentines laboratory has made more than two dozen mutant, ALS-causing enzymes, most of which have only one wrong amino acid out of 153, to try to understand their properties and learn what makes them toxic.

Some of the mutant proteins are very different from the normal protein, but others are virtually identical to the normal protein yet they all cause the disease, said Valentine, a member of UCLAs Molecular Biology Institute. That was the real mystery. You wrack your brain: What is similar among all these proteins" They seem so different. How can they all cause the same disease"

Now Valentine and her colleagues, including Ivano Bertini, professor of chemistry at the University of Florence and director of the European Magnetic Resonance Center, think they know. In ALS patients, the proteins copper and zinc may not be there at all. They present evidence for this hypothesis in new research published in Proceedings of the National Academy of Sciences, currently online and available in the journals July 3 print edition.

If we keep the metals entirely out of the protein, we can explain the toxicity, since even the normal protein forms aggregate at physiological conditions when the metals are gone, Valentine said. It was such a puzzle, but this hypothesis can solve it.

If scientists can figure out why ALS patients lack the copper and zinc, that would be a major advance that could lead to trea
'"/>

Contact: Stuart Wolpert
swolpert@support.ucla.edu
310-206-0511
University of California - Los Angeles
27-Jun-2007


Page: 1 2 3 4

Related medicine news :

1. Italian doctors get their information on medicines from drug company sales reps
2. Italian public smoking ban leads to fall in hospital heart attack admissions in under 60s
3. Italian researchers find fenretinide cuts the risk of second breast cancers in young women
4. UPMC joins Italian government to create $398 million biomedical research center in Sicily
5. Italian law on ART brings problems for doctors and patients
6. Northwestern chemists develop new method for synthesizing anti-cancer flavonoids
7. Red delicious, Northern Spy apples have most antioxidants, chemists find
8. Blood-thinning drugs need closer monitoring
9. Study puts us one step closer to understanding the function of sleep
10. A closer look inside our lungs -- Penn researchers develop 2 novel imaging techniques
11. Federal government needs to take closer look at assisted living facilities

Post Your Comments:
(Date:5/21/2013)... Benefit Express Services, LLC, a leader in ... will be hosting a free Workplace Wellness webinar on ... The presentation will focus on making sure your workplace ... Health Care Reform Requirements. The team will also share ... Express regularly hosts free educational webinars on issues that ...
(Date:5/21/2013)... Three major Ohio universities and four hospitals have ... a new collaborative research program aimed exclusively at finding ... Dimes intends to invest $10 million in the program ... Prematurity Research Center -- Ohio Collaborative is a unique ... the March of Dimes. "This new transdisciplinary, team-based research ...
(Date:5/21/2013)... 2013 EMBO announced today that 52 outstanding researchers ... membership. Forty-three of the researchers reside in Europe and ... nine Associate Members from Canada, China, India, Japan and ... 1600 life scientists. , "Our members are the basis ... Maria Leptin said. "We have been building our network ...
(Date:5/21/2013)... Healthcare Solutions, the parent company ... announced that it was honored to receive the ... Conferred annually, the Innovation Award recognizes a ... cutting edge programs that improves cost and/or quality ... for its clinical and IT solutions that have ...
(Date:5/21/2013)... Two-thirds of patients who have been diagnosed ... that they engage in at least one type of ... findings from the National Health and Wellness Survey ... research will be presented today at the 18th Annual ... Outcomes Research) in New Orleans. , “Cancer ...
Breaking Medicine News(10 mins):Health News:Benefit Express to Host Workplace Wellness Webinar 2Health News:New multi-million dollar research center aims to solve the mystery of premature birth 2Health News:New multi-million dollar research center aims to solve the mystery of premature birth 3Health News:EMBO announces 52 new members for 2013 2Health News:Healthcare Solutions Receives Innovation Award From Catamaran 2Health News:Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research 2Health News:Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research 3
(Date:5/21/2013)... May 21, 2013  BioRestorative Therapies, Inc. ("BRT" or ... focused on developing stem cell based therapies for various ... , its President and CEO, will be presenting at ... will be held on Thursday, May 30, 2013 at ... Street in New York City.  Mr. Weinreb,s presentation will ...
(Date:5/21/2013)... May 21, 2013  AcelRx Pharmaceuticals, Inc. ... pharmaceutical company focused on the development and ... of acute and breakthrough pain, today announced ... Phase 3 study of its investigational sublingual ... System), the primary efficacy endpoint was achieved.  ...
(Date:5/21/2013)...   RxAlly , a first-of-its-kind alliance of ... publication of a white paper entitled Personalized Pharmacist ... white paper highlights an unprecedented solution for improving ... to avert strains on the health care system. ... range of individually-tailored, pharmacist-provided clinical and consultative services ...
Breaking Medicine Technology:BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 2BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 3Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 2Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 3Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 4Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 5Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 6Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 7Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 8Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 9Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 10RxAlly Releases White Paper on Necessity of Personalized Pharmacist Care 2RxAlly Releases White Paper on Necessity of Personalized Pharmacist Care 3
Cached News: